BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 9074532)

  • 21. Technetium-99m-tetrofosmin scintigraphy in pulmonary tuberculosis.
    Degirmenci B; Kilinc O; Cirak KA; Capa G; Akpinar O; Halilcolar H; Durak H; Akkoclu A; Derebek E; Ucan ES
    J Nucl Med; 1998 Dec; 39(12):2116-20. PubMed ID: 9867153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease.
    Sridhara BS; Braat S; Rigo P; Itti R; Cload P; Lahiri A
    Am J Cardiol; 1993 Nov; 72(14):1015-9. PubMed ID: 8213580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative comparison of planar and SPECT normal data files of thallium-201, technetium-99m-sestamibi, technetium-99m-tetrofosmin and technetium-99m-furifosmin.
    Naruse H; Daher E; Sinusas A; Jain D; Natale D; Mattera J; Makuch R; Wackers FJ
    J Nucl Med; 1996 Nov; 37(11):1783-8. PubMed ID: 8917175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences between 99mTc-sestamibi and 99mTc-tetrofosmin uptake in thyroid and salivary glands: comparison with 99mTc-pertechnetate in 86 subjects.
    Giordano A; Meduri G; Marozzi P; Rubini G; Burroni L; Cappagli M
    Nucl Med Commun; 2003 Mar; 24(3):321-6. PubMed ID: 12612474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 201Tl, 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin: relative retention and clearance kinetics in retrogradely perfused guinea pig hearts.
    Schaefer WM; Moka D; Brockmann HA; Schomaecker K; Schicha H
    Nucl Med Biol; 2002 Feb; 29(2):243-54. PubMed ID: 11823130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does P-glycoprotein have a role in the lung clearances of inhaled 99mTc-sestamibi and 99mTc-tetrofosmin?
    Cheow HK; Ruparelia P; Shankar S; Szczepura KR; Ballinger JR; Hartman NG; Chilvers ER; Peters AM
    Nucl Med Commun; 2009 Aug; 30(8):617-21. PubMed ID: 19474770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study.
    Kapur A; Latus KA; Davies G; Dhawan RT; Eastick S; Jarritt PH; Roussakis G; Young MC; Anagnostopoulos C; Bomanji J; Costa DC; Pennell DJ; Prvulovich EM; Ell PJ; Underwood SR
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1608-16. PubMed ID: 12458395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technetium-99m sestamibi and tetrofosmin myocardial single-photon emission tomography: can we use the same reference data base?
    Widding A; Hesse B; Gadsboll N
    Eur J Nucl Med; 1997 Jan; 24(1):42-5. PubMed ID: 9044875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of time on liver clearance of technetium-99m-tetrofosmin in patients with acute chest pain: when should imaging begin?
    Mann A; Ahlberg AW; White MP; Cross DM; Piriz J; Morris RS; Heller GV
    J Nucl Med Technol; 1998 Sep; 26(3):186-90. PubMed ID: 9755438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 in vitro and in vivo.
    Bernard BF; Krenning EP; Breeman WA; Ensing G; Benjamins H; Bakker WH; Visser TJ; de Jong M
    Nucl Med Biol; 1998 Apr; 25(3):233-40. PubMed ID: 9620628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of 99mTcN-15C5 as a new myocardial perfusion imaging agent in normal dogs and canines with coronary stenosis.
    Fang W; Liu Y; Zhu L; Kim YS; Liu S; He ZX
    Nucl Med Commun; 2008 Sep; 29(9):775-81. PubMed ID: 18677204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol.
    Jain D; Wackers FJ; Mattera J; McMahon M; Sinusas AJ; Zaret BL
    J Nucl Med; 1993 Aug; 34(8):1254-9. PubMed ID: 8326381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The breast cancer cell line MCF7 as a model of 99mTc-SestaMIBI, 99mTc-tetrofosmin and 99mTc-Medronate incorporation.
    Molteni SN; Seregni E; Botti C; Martinetti A; Ferrari L; Crippa F; Bombardieri E
    Anticancer Res; 1999; 19(1A):255-9. PubMed ID: 10226551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extraction and retention of technetium-99m Q12, technetium-99m sestamibi, and thallium-201 in isolated rat heart during coronary acidemia.
    McGoron AJ; Gerson MC; Biniakiewicz DS; Roszell NJ; Washburn LC; Millard RW
    Eur J Nucl Med; 1997 Dec; 24(12):1479-86. PubMed ID: 9391182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of myocardial viability using perfusion cardiac SPECT. 201-thallium rest/redistribution, 201-thallium rest/reinjection and technetium 99m tetrofosmin rest/postnitrates].
    Flotats Giralt A; Carrió Gasset I; Estorch Cabrera M; Bernà Roqueta L; Catafau Alcántara AM; Marí Aparici C; Ballester Rodés M
    Rev Esp Cardiol; 1998; 51 Suppl 1():45-52. PubMed ID: 9549398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease.
    Matsunari I; Fujino S; Taki J; Senma J; Aoyama T; Wakasugi T; Hirai J; Saga T; Ichiyanagi K; Hisada K
    J Nucl Med; 1995 Nov; 36(11):1961-7. PubMed ID: 7472582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimation of myocardial perfusion and viability using simultaneous 99mTc-tetrofosmin--FDG collimated SPECT.
    Fukuchi K; Katafuchi T; Fukushima K; Shimotsu Y; Toba M; Hayashida K; Takamiya M; Ishida Y
    J Nucl Med; 2000 Aug; 41(8):1318-23. PubMed ID: 10945521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial uptake of technetium-99m-furifosmin (Q12) versus technetium-99m-sestamibi (MIBI).
    Bangard M; Bender H; Grünwald F; Hümmelgen M; Willkomm P; Palmedo H; Lüderitz B; Biersack HJ
    Nuklearmedizin; 1999; 38(6):189-91. PubMed ID: 10510802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of cardiac to hepatic uptake of 99mTc-tetrofosmin with and without adenosine infusion to predict the presence of haemodynamically significant coronary artery disease.
    Squires SR; Bushnell DL; Menda Y; Graham MM
    Nucl Med Commun; 2005 Jun; 26(6):513-8. PubMed ID: 15891594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.